Calmille Tablet 1mg

Country: মাল্যাশিয়া

ভাষা: ইংরেজি

সূত্র: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

সক্রিয় উপাদান:

ALPRAZOLAM

থেকে পাওয়া:

MILRIN PHARMACEUTICAL CO. (M) SDN BHD

INN (International Name):

ALPRAZOLAM

প্যাকেজ ইউনিট:

60tablet Tablets

Manufactured by:

PT NOVELL PHARMACEUTICAL LABORATORIES.

তথ্য লিফলেট

_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP) _
CALMILLE TABLET 1MG
_Alprazolam 1mg _
_ _
_ _
_ _
_ _
_ _
_ _
1
WHAT IS IN THIS LEAFLET
1.
What Calmille is used for
2.
How Calmille works
3.
Before you take Calmille
4.
How to take Calmille
5.
While you are using it
6.
Possible side effects
7.
Storage and disposal of Calmille
8.
Product description
9.
Manufacturer
and
Product
Registration Holder
10.
Date of Revision
WHAT CALMILLE IS USED FOR
Calmille
is
used
to
treat
severe
anxiety,
severe
anxiety
associated
with depression and panic disorders.
HOW CALMILLE WORKS
Calmille is a tranquillizer containing
the
active
ingredient
alprazolam.
Alprazolam
belongs
to
one
of
a
group
of
medicines
called
benzodiazepines.
Benzodiazepines
affect chemical activity in the brain
to
promote
sleep
and
to
reduce
anxiety and worry.
BEFORE YOU TAKE CALMILLE
-
_When you must not use it _
Do not take Calmille if:

You are allergic to alprazolam or
other
similar
benzodiazepine
medicines, or to any of the other
ingredients

You are with acute narrow-angle
glaucoma,
myasthenia
gravis
(weakness
of
skeletal
muscles),
severe
respiratory
insufficiency,
sleep apnoea syndrome (condition
where breathing becomes irregular
even stopping for a short period
while you are asleep), severe liver
problems.
Do not take this medicine if any of
the above applies to you. If you are
not
sure,
talk
to
your
doctor
or
pharmacist before taking Calmille.
-
_Before start to take Calmille _
Check
with
your
doctor
or
pharmacist before taking Tramille if
you:

Are pregnant, think you might be
pregnant
now,
are
planning
to
become
pregnant
or
if
you
are
breastfeeding

Have ever felt so depressed that
you have thought about taking your
own life

Have
ever
suffered
any
mental
illness
that
requires
hospital
treatment

Have
problems
with
your
lungs,
kidneys or liver

Have abused drugs or alcohol in
the past of find it difficult to stop
taking
medicines,
drinking
or
taking
drugs.
Your
doctor
may
want to give you special help when
you
need
to
stop
taking
t

পণ্য বৈশিষ্ট্য

Withdrawal symptoms: Once physical dependence has developed, abrupt
termination of treatment will be accompanied by withdrawal symptoms.
These
may
consist
of
headaches,
muscle
pain,
extreme
anxiety,
tension,
restlessness, confusion, irritability and insomnia. In severe cases
the following
symptoms
may
occur:
derealization,
depersonalisation,
hyperacusis,
numbness and tingling of the extremities, hypersensitivity to light,
noise and
physical
contact,
hallucinations
or
epileptic
seizures
(see
section
Recommended Dose).
During
discontinuation
of
alprazolam
treatment,
the
dosage
should
be
reduced slowly in keeping with good medical practice. It is suggested
that the
daily dosage of alprazolam be decreased by no more than 0.5 mg every
three
days. Some patients may require even slower dosage reduction.
Rebound insomnia and anxiety: a transient syndrome whereby the
symptoms
that led to treatment with a benzodiazepine recur in an enhanced form
may
occur on withdrawal of treatment. It may be accompanied by other
reactions
including mood changes, anxiety or sleep disturbances and
restlessness. Since
the
risk
of
withdrawal
phenomena/rebound
phenomena
is
greater
after
abrupt discontinuation of treatment, it is recommended that the dosage
be
decreased gradually by no more than 0.5 mg every three days. Some
patients
may require an even slower dose reduction (see section Recommended
Dose).
_DURATION OF TREATMENT_
The
duration
of
treatment
should
be
as
short
as
possible
(see
section
Recommended Dose) depending on the indication, but should not exceed
eight to twelve weeks including tapering off process. Extension beyond
these
periods
should
not
take
place
without
re-evaluation
of
the
situation.
It may be useful to inform the patient when treatment is started that
it will be
of
limited
duration
and
to
explain
precisely
how
the
dosage
will
be
progressively decreased. Moreover it is important that the patient
should be
aware of the possibility of rebound phenomena, thereby minimising
anxiety
over such symptoms should they occur whi